Sage Journals: Discover world-class research

Retricted access

Research article

First published 2016-8-4

Real-life experience with fampridine (Fampyra ® ) for patients with multiple sclerosis and gait disorders

Yara Dadalti Fragoso, Tarso Adoni, Soniza Vieira Alves-Leon [...]

NeuroRehabilitation

Open access

Research article

First published 2016-2

Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial

Raymond Hupperts, Jan Lycke, Christine Short [...]

Multiple Sclerosis Journal

Open access

Review article

First published 2018

Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience. Report of an expert meeting

Philipp Albrecht, Ingrid Kristine Bjørnå, David Brassat [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2016-10

Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern

Björn Zörner, Linard Filli, Katja Reuter [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2019

Nonwalking response to fampridine in patients with multiple sclerosis in a real-world setting

Francisco Alejandro Rodriguez-Leal, Rocco Haase, Katja Akgün [...]

Sage Open Chronic Disease

Retricted access

Research article

First published 2018-9

Fampridine response in MS patients with gait impairment in a real-world setting: Need for new response criteria?

Francisco Alejandro Rodriguez-Leal, Rocco Haase, Katja Thomas [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2007-04

Fampridine-SR in multiple sclerosis: a randomized,double-blind,placebo-controlled,dose-ranging study

A.D. Goodman, J.A. Cohen, A. Cross [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2016-6

Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine

Richard Macdonell, Guy Nagels, David-Axel Laplaud [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2022

Efficacy of prolonged-release fampridine versus placebo on walking ability,dynamic and static balance,physical impact of multiple sclerosis,and quality of life: an integrated analysis of MOBILE and ENHANCE

Raymond Hupperts, Claudio Gasperini, Jan Lycke [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2008-10

Sustained-Release Fampridine for Symptomatic Treatment of Multiple Sclerosis

Anne R Korenke, Michael P Rivey, Douglas R Allington

Annals of Pharmacotherapy

Search results